$SLXP Recent News Drug companies Salix, Intercept

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:06 PM

$SLXP Recent News

Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Sears leaps on REIT talk; First Solar drops on weak results 10:15 a.m. Nov. 7, 2014 - Sue Chang
Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:45 a.m. Nov. 7, 2014 - Shawn Langlois
Disney’s stock slides as quarterly earnings lack magic 7:04 p.m. Nov. 6, 2014 - Sue Chang
Salix Pharma shares fall on disappointing outlook, CFO resignation 6:54 p.m. Nov. 6, 2014 - Wallace Witkowski
Scuttled ‘inversion’ deals pile up in wake of Treasury rules 3:14 p.m. Oct. 27, 2014 - Robert Schroeder
In focus: Volatility ramps up 5:35 p.m. Oct. 8, 2014 - Lawrence G. McMillan
RadioShack gets a jolt from financing report; Mylan rises 8:22 a.m. Oct. 3, 2014 - Sue Chang
Salix shares jump 5.9% premarket as merger plan is cancelled 7:14 a.m. Oct. 3, 2014 - Silvia Ascarelli
What could scare markets over upcoming earnings, and Buffett’s onto something 6:09 a.m. Oct. 3, 2014 - Barbara Kollmeyer
Salix, Cosmo cancel merger amid inversion crackdown 3:44 a.m. Oct. 3, 2014 - Chip Cummins
Pharma love triangle is a win, win, win for investors 1:11 p.m. Oct. 2, 2014 - The Trading Deck
T. Rowe Price urges Allergan to drop Salix bid 3:38 p.m. Sept. 26, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Actavis's Salix play undermines Allergan defense 11:43 a.m. Sept. 24, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:42 a.m. Sept. 24, 2014 - Russ Britt
Pershing threatens to sue Allergan if no holder vote held on Salix deal 8:28 a.m. Sept. 23, 2014 - David Benoit
Botox maker Allergan rejected Actavis takeover bid 6:18 p.m. Sept. 22, 2014 - Jonathan D. Rockoff
In focus: Market giving mixed signals 7:02 p.m. Sept. 17, 2014 - Lawrence G. McMillan

Actavis Says 'Let's Make A Deal' 9:42 a.m. Today - Seeking Alpha
Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog 2:56 p.m. Nov. 10, 2014 - Zacks.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock 9:51 a.m. Nov. 10, 2014 - TheStreet.com
Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold 9:35 a.m. Nov. 10, 2014 - TheStreet.com
Deutsche Bank Slashes Price Target On Salix Pharmaceuticals 9:04 a.m. Nov. 10, 2014 - benzinga.com
Salix Pharmaceuticals, Ltd. (SLXP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 10, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – DVAX ACHN BMRN SLXP 6:30 a.m. Nov. 10, 2014 - InvestorPlace.com
'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock? 5:00 a.m. Nov. 8, 2014 - TheStreet.com
Health Sell-Offs Drag On IBD 50 6:31 p.m. Nov. 7, 2014 - Investors Business Daily
Market News: Sears, Salix Pharmaceuticals, Walt Disney 4:38 p.m. Nov. 7, 2014 - TheStreet.com
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data 4:22 p.m. Nov. 7, 2014 - TheStreet.com
Ackman Calls for Auction of Allergan 3:38 p.m. Nov. 7, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour 3:19 p.m. Nov. 7, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, Intercept Pharmaceuticals, Extended Stay America 12:38 p.m. Nov. 7, 2014 - benzinga.com
Salix Pharmaceuticals (SLXP) Earnings Report: Q3 2014 Conference Call Transcript 11:30 a.m. Nov. 7, 2014 - TheStreet.com
Salix Q3 Earnings Marred by Inventory Issues, Cuts View - Analyst Blog 11:09 a.m. Nov. 7, 2014 - Zacks.com
Cramer: Salix Pharmaceuticals' Audit Committee Review Is Concerning 10:54 a.m. Nov. 7, 2014 - TheStreet.com
Benzinga's Top Downgrades 8:56 a.m. Nov. 7, 2014 - benzinga.com

Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk 9:05 a.m. Today - PR Newswire - PRF
SALIX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Salix Pharmaceuticals Ltd. - SLXP 10:00 p.m. Nov. 10, 2014 - GlobeNewswire
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals, Ltd. 5:27 p.m. Nov. 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Salix Pharmaceuticals, Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 6, 2015 -- SLXP 4:04 p.m. Nov. 10, 2014 - GlobeNewswire
Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd. 12:09 p.m. Nov. 10, 2014 - PR Newswire - PRF
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals Ltd. -- SLXP 11:40 a.m. Nov. 10, 2014 - GlobeNewswire
Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation 9:30 a.m. Nov. 10, 2014 - GlobeNewswire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP) 11:12 p.m. Nov. 7, 2014 - GlobeNewswire
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO 10:00 p.m. Nov. 7, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd. 8:10 p.m. Nov. 7, 2014 - PR Newswire - PRF
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws 5:23 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investigation on Behalf of Salix Pharmaceuticals, Ltd. Investors Announced by Law Offices of Howard G. Smith 3:32 p.m. Nov. 7, 2014 - BusinessWire - BZX
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP 3:10 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Salix Pharmaceuticals, Ltd. 2:02 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Salix Pharmaceuticals Ltd. 1:01 p.m. Nov. 7, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Ltd. Investigated by Block & Leviton LLP After The Company Announces Resignation Of Its Chief Financial Officer And Reduced Financial Forecasts 11:09 a.m. Nov. 7, 2014 - PR Newswire - PRF
Recover Losses: Ademi & O'Reilly, LLP Investigates Possible Securities Fraud of Salix Pharmaceuticals, Ltd. 10:08 a.m. Nov. 7, 2014 - GlobeNewswire
SALIX SHAREHOLDER ALERT: Investor Rights Firm Johnson & Weaver, LLP Announces Investigation of Salix Pharmaceuticals Ltd. 7:20 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 3Q2014 Results 4:14 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Appoints Acting Chief Financial Officer 4:04 p.m. Nov. 6, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Zepp Health's Q2 2026 Results: Growth Amid Struggles

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Acer's New Monitors: ePaper, Triple Displays & More

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Volato Group Faces Merger Scrutiny Amid SOAR Deal

Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...

Kareem's Lebanese Kitchen: A Culinary Tribute to Maryland

Embracing Tradition with a Modern Twist Well, here's to new beginnings wrapped in old flavors, folks. September 1, 2026, marks the arrival of Kareem's Lebanese Kitchen at Rio Lakefront in Gaithersburg, Maryland. It's where the Mediterranean meets the Chesapeake in an unexpected culinary celebration. Chef Rachid Eido's Legacy Third-generation Lebanese Chef Rachid Eido is...

RealityMine Appoints CPO Amidst Strong Growth Momentum

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Kroger's Strategic Shift: Ibbotson's Bold New Charge

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Innventure Faces Class Action Over Alleged Deception

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...